Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 98.85% is in line with its 5-year average of 90.67%, near the high end of its 5-year range (-117742.86%–100.00%).
1.44% above its 12-month average of 97.45%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 94.36%.
GROSS MARGIN
98.85%
GROSS MARGIN AVG TTM
97.45%
GROSS MARGIN AVG 3Y
95.31%
GROSS MARGIN AVG 5Y
90.67%
GROSS MARGIN AVG 10Y
75.39%
GROSS MARGIN AVG 15Y
-48.44%
GROSS MARGIN AVG 20Y
62.91%
CURRENT VS TTM AVG
+1.44%
CURRENT VS 3Y AVG
+3.71%
CURRENT VS 5Y AVG
+9.02%
CURRENT VS 10Y AVG
+31.11%
CURRENT VS 15Y AVG
+304.06%
CURRENT VS 20Y AVG
+57.13%
SECTOR MEDIAN · HEALTHCARE
41.38%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
+138.88%
vs the sector median at left
Lexicon Pharmaceuticals, Inc.
Market Cap
$772.90M
Gross Margin
98.85%
TTM Avg
97.45%
3Y Avg
95.31%
5Y Avg
90.67%
Market Cap
$778.22M
Gross Margin
34.32%
TTM Avg
34.39%
3Y Avg
32.85%
5Y Avg
32.95%
Market Cap
$783.39M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$763.35M
Gross Margin
40.44%
TTM Avg
20.22%
3Y Avg
20.22%
5Y Avg
20.22%
Market Cap
$786.39M
Gross Margin
10.37%
TTM Avg
19.20%
3Y Avg
18.44%
5Y Avg
17.81%
Market Cap
$759.25M
Gross Margin
65.99%
TTM Avg
63.07%
3Y Avg
62.20%
5Y Avg
62.16%
Market Cap
$782.66M
Gross Margin
97.42%
TTM Avg
97.90%
3Y Avg
98.95%
5Y Avg
-3197.94%
Market Cap
$800.49M
Gross Margin
94.30%
TTM Avg
95.84%
3Y Avg
95.72%
5Y Avg
72.44%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Lexicon Pharmaceuticals, Inc. (LXRX) | $772.90M | 98.85% | 97.45% | 95.31% | 90.67% |
| Varex Imaging Corporation (VREX)vs › | $778.22M | 34.32% | 34.39% | 32.85% | 32.95% |
| Sana Biotechnology, Inc. (SANA)vs › | $783.39M | 0.00% | 0.00% | 0.00% | 0.00% |
| Attovia Therapeutics, Inc. (ATTO)vs › | $763.35M | 40.44% | 20.22% | 20.22% | 20.22% |
| AdaptHealth Corp. (AHCO)vs › | $786.39M | 10.37% | 19.20% | 18.44% | 17.81% |
| Mesa Laboratories, Inc. (MLAB)vs › | $759.25M | 65.99% | 63.07% | 62.20% | 62.16% |
| Geron Corporation (GERN)vs › | $782.66M | 97.42% | 97.90% | 98.95% | -3197.94% |
| Apnimed, Inc. (APMD)vs › | $750.67M | N/A | N/A | N/A | N/A |
| Gyre Therapeutics, Inc. (GYRE)vs › | $800.49M | 94.30% | 95.84% | 95.72% | 72.44% |
| InMode Ltd. (INMD)vs › | $803.87M | 76.52% | 79.43% | 81.57% | 82.72% |
Gross Margin
98.8%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 94.36% |
| 2026-03-31 | 99.49% |
| 2025-12-31 | 94.19% |
| 2025-09-30 | 99.93% |
| 2025-06-30 | 99.28% |
| 2025-03-31 | 97.62% |
| 2024-12-31 | 2.34% |
| 2024-09-30 | 95.94% |
| 2024-06-30 | 89.92% |
| 2024-03-31 | 84.51% |
| 2023-12-31 | -2012.82% |
| 2023-09-30 | 95.68% |
| 2023-06-30 | 97.48% |
| 2023-03-31 | 100.00% |
| 2022-12-31 | -267.86% |
| 2022-09-30 | 100.00% |
| 2022-06-30 | 100.00% |
| 2022-03-31 | -194.59% |
| 2021-12-31 | -117742.86% |
| 2021-09-30 | 100.00% |
| 2021-06-30 | -4283.33% |
| 2021-03-31 | -46600.00% |
| 2020-12-31 | -398.49% |
| 2020-09-30 | 90.46% |
| 2020-06-30 | 92.06% |
| 2020-03-31 | 92.90% |
| 2019-12-31 | 91.13% |
| 2019-09-30 | 99.80% |
| 2019-06-30 | 86.29% |
| 2019-03-31 | 94.00% |
| 2018-12-31 | 96.67% |
| 2018-09-30 | 91.96% |
| 2018-06-30 | 93.91% |
| 2018-03-31 | 97.89% |
| 2017-12-31 | 98.37% |
| 2017-09-30 | 97.78% |
| 2017-06-30 | 95.54% |
| 2017-03-31 | 98.77% |
| 2016-12-31 | -75.37% |
| 2016-09-30 | -89.53% |
| 2016-06-30 | -140.01% |
| 2016-03-31 | -196.16% |
| 2015-12-31 | 76.08% |
| 2015-09-30 | -3983.22% |
| 2015-06-30 | -5423.67% |
| 2015-03-31 | -1064.34% |
| 2014-12-31 | 6.75% |
| 2014-09-30 | -5653.70% |
| 2014-06-30 | -3034.17% |
| 2014-03-31 | -8547.29% |
| 2013-12-31 | -1337.09% |
| 2013-09-30 | -10572.27% |
| 2013-06-30 | -10971.03% |
| 2013-03-31 | -5546.39% |
| 2012-12-31 | -9528.44% |
| 2012-09-30 | -5059.14% |
| 2012-06-30 | 100.00% |
| 2012-03-31 | 100.00% |
| 2011-12-31 | 100.00% |
| 2011-09-30 | 100.00% |
| 2011-06-30 | 100.00% |
| 2011-03-31 | 100.00% |
| 2010-12-31 | 100.00% |
| 2010-09-30 | 100.00% |
| 2010-06-30 | 100.00% |
| 2010-03-31 | 100.00% |
| 2009-12-31 | 100.00% |
| 2009-09-30 | 100.00% |
| 2009-06-30 | 100.00% |
| 2009-03-31 | 100.00% |
| 2008-12-31 | 100.00% |
| 2008-09-30 | 100.00% |
| 2008-06-30 | 100.00% |
| 2008-03-31 | 100.00% |
| 2007-12-31 | 100.00% |
| 2007-09-30 | 100.00% |
| 2007-06-30 | 100.00% |
| 2007-03-31 | 100.00% |
| 2006-12-31 | 100.00% |
| 2006-09-30 | 100.00% |
| 2006-06-30 | 100.00% |
| 2006-03-31 | 100.00% |
| 2005-12-31 | 100.00% |
| 2005-09-30 | 100.00% |
| 2005-06-30 | 100.00% |
| 2005-03-31 | 100.00% |
| 2004-12-31 | 100.00% |
| 2004-09-30 | 100.00% |
| 2004-06-30 | 100.00% |
| 2004-03-31 | 100.00% |
| 2003-12-31 | 100.00% |
| 2003-09-30 | 100.00% |
| 2003-06-30 | 100.00% |
| 2003-03-31 | 100.00% |
| 2002-12-31 | 100.00% |
| 2002-09-30 | 100.00% |
